LIANY vs REGN: Which Stock is Better?
Side-by-side comparison of Lianbio and Regeneron Pharmaceuticals Inc in 2026
LIANY
Lianbio
$0.12
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | LIANY | REGN | Winner |
|---|---|---|---|
| Market Cap | $13.31M | $78.87B | REGN |
| P/E Ratio | N/A | 17.98 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze LIANY
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LIANY or REGN a better investment?
Comparing LIANY and REGN: Lianbio has a market cap of $13.31M while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LIANY and REGN?
LIANY (Lianbio) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LIANY or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LIANY or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for LIANY.
Which company is more profitable: LIANY or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for LIANY.
Which is the larger company: LIANY or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $13.31M for LIANY.
Should I buy LIANY or REGN in 2026?
Both LIANY and REGN have investment merit. LIANY trades at $0.12 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LIANY and REGN stock?
Key differences: Market Cap ($13.31M vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).